Frost & Sullivan Recognises ClearDATA with the 2014 North American Healthcare Cloud Leadership Award

 

LONDONDec. 1, 2014-- Based on its recent analysis of the healthcare cloud market, Frost & Sullivan has recognised ClearDATA with the 2014 North American Healthcare Cloud Leadership Award.

ClearDATA's broad product portfolio — comprised of Infrastructure as a Service, Platform as a Service as well as professional and managed services — is testimony to its deep understanding of the complex healthcare and technological landscape. With its superior knowledge of healthcare workflow, compliance and governance, the company delivers secure cloud computing to the entire breadth of healthcare organisations, including hospitals/providers, life sciences, payers and healthcare software companies. ClearDATA currently supports the needs of 310,000 healthcare professionals accessing 110 million healthcare records on its HealthDATA™ cloud computing platform.

"Frost & Sullivan's independent analysis of the healthcare cloud market clearly shows that ClearDATA delivers the utmost standards in compliance, security and performance in HIPAA-compliant cloud computing and managed services," said Frost & Sullivan Research Analyst Shruthi Parakkal. "Their solutions are scalable from small applications to Big Data. They add value in security, interoperability and data warehousing and storage, making health data more secure, accessible and usable."

In line with healthcare customers' need to integrate information from disparate sources, the company developed a dedicated healthcare cloud platform. This platform provides a foundation for secure data extraction, central data warehouses, middleware, and end user presentation layers that enable use of protected health information (PHI) for population health management.

"ClearDATA's key value proposition lies in their pure healthcare-oriented solutions with meaningful ROI and cost reduction," noted Frost & Sullivan Program Director Eramangalath Sujith. "By committing to the standards of 100 percent redundancy, 100 percent network and power uptime, 100 percent assurance of IT business continuity, and 99.999 percent server uptime at a lower cost than on premise solutions, the company has steadily taken a market leading position."

A recent report by Frost & Sullivan, "Opportunities in Healthcare Cloud Application in the US and Europe" (Oct. 2014) concluded that ClearDATA is a key company to watch out for with strong market growth potential in the next 3-5 years.

ClearDATA's leadership in the market is due in large part to its unrivalled expertise in Health Insurance Portability and Accountability Act (HIPAA) compliance. All their solutions adhere to the guidelines set by the National Institute of Standards and Technology and the Common Security Framework certified by Health Information Trust Alliance (HITRUST). Whereas other cloud computing companies may state that their environments can support a HIPAA-compliant architecture and offer a heavily shared compliant model, ClearDATA takes it further by designing, deploying and managing a compliant IT environment in the cloud on behalf of clients.

Since most providers do not have a healthcare IT road map and strategy in place, ClearDATA offers healthcare IT professional services. These services include cloud infrastructure assessment, migration planning, infrastructure design and architecture, security risk assessments, compliance adherence, privacy enablement, policy and procedure development, and implementation of security protocols and technology.

Frost & Sullivan presents this award to the company that has developed a comprehensive product line that caters to the breadth of the market it serves. The award recognises the extent to which the product line meets customer demands, overall impact in terms of customer value as well as increased market share.

Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About ClearDATA
ClearDATA is exclusive to healthcare and is the industry leader in cloud computing, platform and information security services. More than 300,000 healthcare practitioners rely on ClearDATA's secure, HIPAA-compliant, HITRUST CSF-certified cloud HealthDATA™ infrastructure and platform to store, manage, protect and share their patient health information and critical applications. For more information, call (888) 899-2066 or visitwww.cleardata.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:   Start the discussion

Join Us:      Join our community

Subscribe:    Newsletter on "the next big thing"

Register:     Gain access to visionary innovation

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.